These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

143 related articles for article (PubMed ID: 8248521)

  • 1. Lithium selectively potentiates cholinergic activity in rat brain.
    Jope RS
    Prog Brain Res; 1993; 98():317-22. PubMed ID: 8248521
    [No Abstract]   [Full Text] [Related]  

  • 2. Lithium reduces the accumulation of inositol polyphosphate second messengers following cholinergic stimulation of cerebral cortex slices.
    Kennedy ED; Challiss RA; Nahorski SR
    J Neurochem; 1989 Nov; 53(5):1652-5. PubMed ID: 2795023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Neurochemical and behavioural effects of muscarinic acetylcholine receptor agonists.
    Spencer DG; van Rooijen LA; Horváth E; Dompert W; Traber J
    Trends Pharmacol Sci; 1988 Feb; Suppl():61-8. PubMed ID: 3074540
    [No Abstract]   [Full Text] [Related]  

  • 4. Differential effect of lithium on fos protooncogene expression mediated by receptor and postreceptor activators of protein kinase C and cyclic adenosine monophosphate: model for its antimanic action.
    Divish MM; Sheftel G; Boyle A; Kalasapudi VD; Papolos DF; Lachman HM
    J Neurosci Res; 1991 Jan; 28(1):40-8. PubMed ID: 1674966
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lithium, manic-depression, and the chemistry of the brain.
    Samuel D; Gottesfeld Z
    Endeavour; 1973 Sep; 32(117):122-8. PubMed ID: 4126873
    [No Abstract]   [Full Text] [Related]  

  • 6. Lithium augmentation of antidepressant treatment: partially due to an effect on a cholinergic mechanism?
    Dilsaver SC
    Arch Gen Psychiatry; 1988 Jan; 45(1):96-7. PubMed ID: 3337611
    [No Abstract]   [Full Text] [Related]  

  • 7. The effect of lithium on the adrenoceptor-mediated second messenger system in the rat brain.
    Devaki R; Shankar Rao S; Nadgir SM
    J Psychiatry Neurosci; 2006 Jul; 31(4):246-52. PubMed ID: 16862242
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The phosphoinositide signalling system. I. Historical background. II. Effects of lithium on the accumulation of second messenger inositol 1,4,5-trisphosphate in brain cortex slices.
    Hokin LE; Dixon JF
    Prog Brain Res; 1993; 98():309-15. PubMed ID: 8248520
    [No Abstract]   [Full Text] [Related]  

  • 9. Effects of lithium on second messenger systems in the brain.
    Mørk A; Geisler A; Hollund P
    Pharmacol Toxicol; 1992; 71 Suppl 1():4-17. PubMed ID: 1336196
    [No Abstract]   [Full Text] [Related]  

  • 10. Drug research: the ups and downs of lithium.
    Pilcher HR
    Nature; 2003 Sep; 425(6954):118-20. PubMed ID: 12968146
    [No Abstract]   [Full Text] [Related]  

  • 11. Ziskind-Somerfeld research Award. The involvement of guanine nucleotide binding proteins in the pathogenesis and treatment of affective disorders.
    Avissar S; Schreiber G
    Biol Psychiatry; 1992 Mar; 31(5):435-59. PubMed ID: 1581423
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The effects of lithium on norepinephrine turnover and metabolism: basic and clinical studies.
    Schildkraut JJ
    J Nerv Ment Dis; 1974 May; 158(5):348-60. PubMed ID: 4823935
    [No Abstract]   [Full Text] [Related]  

  • 13. Pharmacologic induction of cholinergic system up-regulation and supersensitivity in affective disorders research.
    Dilsaver SC
    J Clin Psychopharmacol; 1986 Apr; 6(2):65-74. PubMed ID: 3517080
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The interaction of RS 86, a centrally acting m-cholinoceptor agonist with M1 and M2 receptors in rat brain and rat heart, respectively.
    Schubert T; Brunner F; Müller WE
    Pharmacopsychiatry; 1988 Nov; 21(6):321-3. PubMed ID: 3244760
    [No Abstract]   [Full Text] [Related]  

  • 15. Cholinergic rebound after chlorpromazine exacerbates lithium muscarinic-induced limbic seizures in rats: implications for psychiatric treatment.
    Bureau YR; Persinger MA
    Psychol Rep; 1991 Aug; 69(1):171-6. PubMed ID: 1660160
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lithium--myth or magic.
    Ashcroft GW
    Tidsskr Nor Laegeforen; 1973 Jun; 93(17):1320-2. PubMed ID: 4591694
    [No Abstract]   [Full Text] [Related]  

  • 17. Subtype selective muscarinic agonists: potential therapeutic agents for Alzheimer's disease.
    Davis R; Raby C; Callahan MJ; Lipinski W; Schwarz R; Dudley DT; Lauffer D; Reece P; Jaen J; Tecle H
    Prog Brain Res; 1993; 98():439-45. PubMed ID: 8248534
    [No Abstract]   [Full Text] [Related]  

  • 18. [The neurobiology of lithium].
    Navón S
    Medicina (B Aires); 1978; 38(1):93-104. PubMed ID: 30878
    [No Abstract]   [Full Text] [Related]  

  • 19. Do lithium and anticonvulsants target the brain arachidonic acid cascade in bipolar disorder?
    Rapoport SI; Bosetti F
    Arch Gen Psychiatry; 2002 Jul; 59(7):592-6. PubMed ID: 12090811
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Negative and positive inotropic responses to muscarinic agonists in guinea pig and rat atria in vitro.
    Eglen RM; Montgomery WW; Whiting RL
    J Pharmacol Exp Ther; 1988 Dec; 247(3):911-7. PubMed ID: 2849676
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.